Longwood Fund Management

Longwood Fund is a premier venture capital firm based in Boston that specializes in the creation and management of early-stage biotechnology companies. Founded in 2010 by industry veterans including Christoph Westphal and Rich Aldrich, the firm employs a unique "company creation" model where its partners often serve as founding executives to drive initial growth. Longwood's portfolio includes some of the most successful names in biotech, such as Alnylam, Vertex, and Momenta, reflecting a track record of translating academic breakthroughs into marketed therapies. The firm focuses on diverse modalities including RNAi, cell therapy, and gene editing to address significant unmet needs in oncology, rare diseases, and immunology. Additionally, Longwood hosts the influential Longwood Healthcare Leaders conferences, fostering high-level collaboration across the life sciences ecosystem.